Athene Announces New Registered Indexed-Linked Annuity
Athene USA, a leading provider of retirement savings products, announced the launch of Athene® Amplify 2.0, a registered index-linked annuity (RILA) that offers next-generation accumulation potential with a level of downside protection in volatile markets, the company announced in a news release.
The annuity is issued by Athene Annuity and Life Company, a subsidiary of Athene.
By offering participation rate strategies in addition to the cap rate strategies offered on most RILA products, Amplify 2.0 gives investors the potential for index-linked interest earnings that may even exceed index returns.1
Currently, investors choosing a six-year term and a 10% downside buffer with a 0.95% annual segment fee can earn uncapped returns equal to 140% of any growth in the S&P 500®.2
“Athene® Amplify 2.0 reflects our commitment to satisfy evolving consumer needs as they plan for retirement,” said Grant Kvalheim, CEO and President of Athene USA. “We’re confident it will become the preferred solution for producers seeking to offer clients more participation in market gains as they manage downside risk.”
Amplify 2.0 includes unique features that can help investors achieve their objectives for long-term asset appreciation in accordance with their individual tolerance for risk.
• Two buffer options, 10 and 20%, for a level of downside protection
• Three term periods to manage market volatility
• Five complementary indices plus two unique crediting options, Milestone Lock and Performance Blend, that give clients more control over their money
An additional product option, Athene® Amplify 2.0 NF, offers the same features with competitive rates and no annual segment fee.
RILAs, also called registered index-linked variable annuities, buffered annuities or structured annuities, are frequently described as a cross between fixed indexed annuities and variable annuities.
Like fixed indexed annuities, registered index-linked annuities provide the opportunity for growth based on the performance of a stock market index, but unlike variable annuities are not stock market investments and do not directly participate in any stock or equity investments.
RILAs differ from fixed indexed annuities in that investors are eligible for higher growth potential but do assume responsibility for a portion of any index decline.
1All Segment Credits, including those with a guaranteed rate of interest, are paid by the insurance company and subject to its claims paying ability.
2A 0.95% annual Segment Fee will be deducted from the Amplify 2.0 annuity’s Segment Value daily and may result in the loss of principal. The Segment Fee is set at issue and guaranteed not to change for the life of the contract. This fee does not apply to values in the Fixed Segment Option.
About Athene USA
Athene USA is an Iowa-domiciled corporation that serves as the U.S. holding company for Athene’s annuity operations in the United States. Headquartered in West Des Moines, Iowa, Athene USA serves customers in all 50 states, and through its predecessor companies, has been serving American consumers for more than 100 years.



California Insurance Commissioner Race Attracts A Crowd
Registered Index-Linked Annuities Achieve Record Growth, Cerulli Reports
Advisor News
- The modern advisor: Merging income, insurance, and investments
- Financial shocks, caregiving gaps and inflation pressures persist
- Americans unprepared for increased longevity
- More investors will seek comprehensive financial planning
- Midlife planning for women: why it matters and how advisors should adapt
More Advisor NewsHealth/Employee Benefits News
- Hospital, clinics hurting as fewer Tri-Cities patients have health care coverage
- Reports on Insurance from State University of New York (SUNY) Albany Provide New Insights (Effects of National Insurance Reforms and State Medicaid Expansions Under the Affordable Care Act on Insurance Coverage Among American Indian and Alaska …): Insurance
- Findings from Kristi Martin et al Has Provided New Information about Managed Care and Specialty Pharmacy (Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countries): Drugs and Therapies – Managed Care and Specialty Pharmacy
- Data on Hypertension Discussed by Denise Wolff and Colleagues (AMCP Market Insights: Getting to the heart of hard-to-control hypertension in managed care): Cardiovascular Diseases and Conditions – Hypertension
- Democratic candidates revive single-payer promise as California's healthcare system faces strain
More Health/Employee Benefits NewsLife Insurance News
- AM Best Assigns Credit Ratings to Tokio Marine Newa Insurance Co., Ltd.
- Earnings roundup: Prudential works to save ‘unique’ Japanese market
- How life insurance became a living-benefits strategy
- Financial Focus : Keep your beneficiary choices up to date
- Equitable-Corebridge merger casts shadow over life insurance earnings
More Life Insurance NewsProperty and Casualty News
- Ohio State Bar Association and ALPS Insurance Reach Agreement for Sale of Ohio Bar's Insurance Provider
- FOR 7TH STRAIGHT YEAR, MEDICAL LIABILITY INSURANCE PREMIUMS CLIMB
- Trump task force recommends sweeping changes to FEMA — but not eliminating it
- Which type(s) of small business insurance does your business need? (Almost) every coverage explained
- FLORIDA HOUSING: Regulated out of reach
More Property and Casualty News